Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Investment

Perpetual launches Barrow Hanley ETF

ANDREW MCKEAN  |  TUESDAY, 7 JUN 2022
Perpetual Asset Management Australia has added to its suite of ETFs, today launching the Barrow Hanley Global Share Fund.

Magellan shares punished after FUM drop

ANDREW MCKEAN  |  MONDAY, 6 JUN 2022
In an update to the ASX this morning, Magellan Financial Group reported that its funds under management dropped $3.6 billion in the month to May 31.

Magellan, Platinum dropped in S&P/ASX rebalance

JAMIE WILLIAMSON  |  MONDAY, 6 JUN 2022
The latest changes to the S&P/ASX Indices see the removal of Magellan Financial Group and Platinum Asset Management from their respective indexes.

Teaminvest creates co-living impact fund

CHLOE WALKER  |  MONDAY, 6 JUN 2022
Teaminvest Private Group (TIP) launched a new wholesale managed fund with a focus on housing affordability, accessibility, and inclusivity.

Pendal launches new charitable investment vehicle

CHLOE WALKER  |  MONDAY, 6 JUN 2022
Pendal has teamed up with Investment Giving Australia to launch a new product in the Australian market that will allow investors to pass fund distributions on to charity.

Boutique takes over Mason Stevens fund

JAMIE WILLIAMSON  |  FRIDAY, 3 JUN 2022
The recently launched Torica Capital has taken over as investment manager of the Mason Stevens Credit Fund.

Investors Mutual, Vaughan Nelson partner

CASSANDRA BALDINI  |  THURSDAY, 2 JUN 2022
Investors Mutual partnered with Vaughan Nelson to launch a global SMID cap strategy, the first of its kind to hit the Australian market.

Yarra adds market neutral fund

JAMIE WILLIAMSON  |  THURSDAY, 2 JUN 2022
Yarra Capital has assumed management of a Karara Capital market neutral fund, bringing on board its portfolio manager.

ETFS Physical Gold to be split 10:1

ANDREW MCKEAN  |  THURSDAY, 2 JUN 2022
ETF Securities is conducting a 10:1 share split on its $2.6 billion ETFS Physical Gold product (GOLD).

HESTA injects $4.4m into Aussie biotech startup

CHLOE WALKER  |  WEDNESDAY, 1 JUN 2022
Sydney-based Inventia Life Science has announced the super fund's direct investment as it develops, manufactures and distributes the RASTRUM 3D bioprinter.